Last Updated 1 March 2021.
4 Vaccines Approved for Use in Argentina
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 67 countries
11 trials in 9 countries
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 39 countries
19 trials in 6 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 58 countries
22 trials in 13 countries
-
Serum Institute of India
Covishield- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 14 countries
2 trials in 1 country
5 Vaccines in Clinical Trials in Argentina
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 67 countries
11 trials in 9 countries
-
CanSino
Ad5-nCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 3 other countries
6 trials in 6 countries
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 3 other countries
6 trials in 17 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 58 countries
22 trials in 13 countries
-
Sinopharm (Beijing)
BBIBP-CorV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 16 other countries
6 trials in 7 countries